Ryan Zimmerman
Stock Analyst at BTIG
(4.53)
# 284
Out of 4,712 analysts
171
Total ratings
60%
Success rate
16.8%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $83.56 | +8.90% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $57.33 | +15.12% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $239.85 | +12.57% | 16 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $151.16 | -1.43% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $534.88 | +4.88% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $367.11 | +7.32% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $5.50 | +81.82% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $85.65 | +23.76% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $22.33 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $106.87 | +17.90% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $79.51 | +25.77% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $66.74 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $34.22 | +113.33% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $24.21 | +118.92% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.46 | +546.55% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.98 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.49 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.75 | +45.45% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.19 | +88.09% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.23 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $22.89 | +127.17% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.53 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $17.25 | +62.32% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $170.97 | +16.98% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $265.12 | +32.02% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $114.99 | +13.05% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $82.01 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $80.74 | +58.53% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $8.38 | +79.00% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $72.60 | +25.34% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.70 | +137.29% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $16.46 | +218.96% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.66 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $83.56
Upside: +8.90%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $57.33
Upside: +15.12%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $239.85
Upside: +12.57%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $151.16
Upside: -1.43%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $534.88
Upside: +4.88%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $367.11
Upside: +7.32%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $5.50
Upside: +81.82%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $85.65
Upside: +23.76%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $22.33
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $106.87
Upside: +17.90%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $79.51
Upside: +25.77%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $66.74
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $34.22
Upside: +113.33%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $24.21
Upside: +118.92%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.46
Upside: +546.55%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.98
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.49
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.75
Upside: +45.45%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.19
Upside: +88.09%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.23
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $22.89
Upside: +127.17%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $17.53
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $17.25
Upside: +62.32%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $170.97
Upside: +16.98%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $265.12
Upside: +32.02%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $114.99
Upside: +13.05%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $82.01
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $80.74
Upside: +58.53%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $8.38
Upside: +79.00%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $72.60
Upside: +25.34%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.70
Upside: +137.29%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $16.46
Upside: +218.96%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $16.66
Upside: -